Skip to content
OpenCapital
Get started

LONA LONA Milestone Liabilities

Milestone Liabilities at other companies

Mannkind logo
MannkindMNKD
$2M-20.6%
HRO
HarrowHROW
$1.75M—
OS Therapies logo
OS TherapiesOSTX
$22.38M0.0%
Celcuity logo
CelcuityCELC
$5M—
OS Therapies logo
OS TherapiesOSTX
$22.38M0.0%
CTO
Citius Oncology, Inc.CTOR
$70M+155%

Other financials

Income statement

See full
Operating income-$17.2M-80.5%
Net income-$32.9M-260%
EPS (diluted)-$1.73+26.1%

Balance sheet

See full
Cash & equivalents$32.8M+24.3%
Total debt$691.0K-38.2%
Total equity$49.3M+32.1%
Total assets$71.6M+64.5%

Cash flow

See full
Operating cash flow-$20.9M-42.5%
CapEx$28.0K-15.2%
Free cash flow-$26.0M+1.1%

Valuation

See full
Market cap$86.33M+223%
Enterprise value$54.18M—

Returns & leverage

See full
Return on equity-298.8%-726pp
Debt / equity0×0.0×
Current ratio10.4×+3.1×

Where this comes from

Reported directly by LONA in its filing.

Tagged under the XBRL concept lona:MilestoneLiabilities.

The official record: LONA’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about LONA's milestone liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LONA's milestone liabilities?
LONA (LONA) reported milestone liabilities of $14.19M in Q1 2026.
What does milestone liabilities mean?
This represents the aggregate value of contingent obligations payable to third parties upon the achievement of specific clinical, regulatory, or commercial development milestones. These liabilities reflect the company's contractual commitments to partners or licensors for the successful advancement of its drug pipeline candidates. Monitoring these obligations is essential for assessing potential future cash outflows and the financial impact of successful R&D progression.